Navigation Links
Actinium Pharmaceuticals Announces The Addition of The Fred Hutchinson Cancer Research Center To Actinium's Multicenter Clinical Trial For Patients With Acute Myeloid Leukemia
Date:8/1/2012

for this study will be patients with newly diagnosed AML who are over the age of 60 years, an age in which many chemotherapy regimens are not tolerated.  In other published third party studies in AML, newly diagnosed patients had better responses than relapsed patients.

About Actimab-A

Actimab-A is a drug candidate construct made using Actinium Pharmaceuticals' proprietary patented technology for arming monoclonal antibodies with alpha emitters actinium 225 and bismuth 213.  Antibodies are used as high precision delivery systems that bring powerful alpha emitters into or immediately next to targeted cancer cells.  Actimab-A consists of the Lintuzumab monoclonal antibody and actinium 225.

Actinium-225 decays by giving off high-energy alpha particles, which kill cancer cells. When actinium decays, it produces a series of daughter atoms, each of which gives off its own alpha particle, increasing the chances that the cancer cell will be destroyed.  The technology was first demonstrated by Dr. David Scheinberg at Memorial Sloan Kettering Cancer Center. 

Lintuzumab is a monoclonal antibody that targets CD33, found on myeloid leukemia cells. It is the humanized version of M195, the antibody initially developed by Dr. David Scheinberg of Memorial Sloan Kettering Cancer Center.

About Actinium Pharmaceuticals

Actinium Pharmaceuticals, Inc.  is a U.S. based biopharmaceutical company that develops innovative alpha particle immunotherapeutics based on its proprietary platform for the therapeutic utilization of alpha particle emitting actinium-225 and bismuth-213 radiopharmaceuticals in association with monoclonal antibodies.

For more information:

Visit our web site www.actiniumpharmaceuticals.com or contact:

Media:

SOURCE Actinium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Actinium Pharmaceuticals Inc. Pays Regulatory Milestone to Abbott Biotherapeutics Corp.
2. Synergy Pharmaceuticals to Present Scientific Posters at the Upcoming Gastroenterology Society Meetings in the U.S. and Europe
3. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
4. Nouveau Life Pharmaceuticals (NOUV) Releases Krill Oil to Support Healthy Cholesterol Levels and Reduce Inflammation
5. Kinex Pharmaceuticals Receives Substantial Strategic Investment
6. Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
7. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
8. Consumers Choosing Organic Alternatives to Traditional Pharmaceuticals
9. Catherine Sohn Elected To Jazz Pharmaceuticals Board Of Directors
10. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
11. Jason Pharmaceuticals, Inc. Reaches Proposed Consent Agreement with FTC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , N.Y. and HAMBURG, Germany , ... announced it is collaborating with Deutsches Elektronen-Synchrotron ( DESY ... Germany , to speed up management and storage ... Big Data and Analytics architecture based on IBM ... per second of data at peak performance and help ...
(Date:8/21/2014)... 21, 2014  Zacks.com announces the list of stocks featured ... analysts discuss the latest news and events impacting stocks and ... Hewlett-Packard (NYSE: HPQ - Free Report ), IBM (NYSE: ... SB - Free Report ), GlaxoSmithKline plc (NYSE: ... FI - Free Report ). Today, Zacks ...
(Date:8/21/2014)... , Aug. 21, 2014  Henry Schein, Inc. (NASDAQ: ... care products and services to office-based dental, animal health and ... two investor conferences in September: , September 4, ... York , NY at 12:50 p.m. ET , September ... in New York , NY at 1:25 p.m. ...
Breaking Medicine Technology:DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11Henry Schein To Present At Two Investor Conferences In September 2
(Date:8/22/2014)... Texas (PRWEB) August 23, 2014 ... Industry” is a professional and in-depth research report ... basic Glucose Meter information, including Glucose Meter definition, ... as industry overview. This research covers the international ... global industry analysis covering macroeconomic environment & economic ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Today, Zane ... new guide on Account-Based Health Plans. , According to ... as a strategy to lower the cost of healthcare ... of medical spending accounts, however, can be confusing. , ... to learn the four main types of ABHPs. It ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 MyWriters.com ... is written by marketing experts for marketers to help ... has caught the attention of Shane Michaels, prompting an ... Internet marketing in any way knows that content is ... the industry,” reports Michaels. “But even though content is ...
(Date:8/22/2014)... CA (PRWEB) August 22, 2014 Buying a ... an adult who is unsure about available coverage types by ... providing principal life insurance policy pricing to the public using ... use of this tool is free and is expected to ... available to the public throughout the U.S. The system is ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Millennium Treatment Group ... resulting in a high level of drug use among teenagers. ... fight against drug addiction and work to minimize drug abuse. ... of alcohol and drug addiction in history. According to the ... estimated 23.9 million Americans aged 12 or older—or 9.2 percent ...
Breaking Medicine News(10 mins):Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 2Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 3Health News:My Writers: Review Exposes Online Source for Quality Marketing Content 2Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2
... pulmonary fibrosis often do not get referred to a tertiary ... a higher death rate. Better methods of early ... (NEW YORK, NY, July 1, 2011) Idiopathic pulmonary ... the predominant condition leading to lung transplantation nationwide. Columbia University ...
... have discovered the first of an entirely new class ... development of blood vessels. In a report in ... the investigators describe how a compound derived from a ... to interfere with blood vessel formation in animal models ...
... the American College of Radiology suggests that self-referral ... diagnostic imaging growth. Self-referred imaging is identified as ... to their own on-site imaging services or the referral of ... financial interest. In the current political and ...
... Reporter , THURSDAY, June 30 (HealthDay News) -- Annual low-dose ... 20 percent in heavy smokers and formerly heavy smokers, compared ... results of a major National Cancer Institute study released on ... major advance in efforts to combat lung cancer deaths. By ...
... up and down the court aspiring to NBA stardom. Now, ... to achieving their hoop dreams: sleep. In a study ... Mah, a researcher in the Stanford Sleep Disorders Clinic and ... college level were able to improve their on-the-court performance by ...
... Samuel Waxman Cancer Research Foundation have partnered to establish a ... the two Foundations are proud to announce the award of ... School of Medicine in Atlanta. Van Meir,s research aims to ... the Ewing sarcoma family of tumors (ESFT) oncoprotein. Ewing ...
Cached Medicine News:Health News:Delayed access to tertiary care associated with higher death rate from type of pulmonary fibrosis 2Health News:Mass. General team identifies new class of antiangiogenesis drugs 2Health News:Self-referral: A significant factor in imaging growth 2Health News:Who Should Get a CT Scan to Screen for Lung Cancer? 2Health News:Who Should Get a CT Scan to Screen for Lung Cancer? 3Health News:Who Should Get a CT Scan to Screen for Lung Cancer? 4Health News:Who Should Get a CT Scan to Screen for Lung Cancer? 5Health News:Snooze you win? It's true for achieving hoop dreams, says Stanford study 2Health News:Snooze you win? It's true for achieving hoop dreams, says Stanford study 3Health News:Targeting the Ewing sarcoma family of tumors 2
... a minimum results in less emotional trauma ... the clinician. The innovative motor plus saw ... lighter package. In addition, the unique design ... more user comfort. Plus automated multi-speed controls ...
The True/Fix Cannulated Bone Screw System contains 7.0mm large cannulated bone screws and 3.5mm cortical and 4.0mm cannulated cancellous bone screws....
LEMAIRE stapes are stainless steel staples indicated for ligament fixation....
... Osteotomies and ligament ... a small number of ... Arthrodesis is the most ... of suitable staples allow ...
Medicine Products: